ResMed (RMD)
(Delayed Data from NYSE)
$233.98 USD
-4.45 (-1.87%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $233.62 -0.36 (-0.15%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth A Momentum A VGM
ResMed (RMD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$233.44 | $270.00 | $180.00 | -2.09% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for ResMed comes to $233.44. The forecasts range from a low of $180.00 to a high of $270.00. The average price target represents a decline of 2.09% from the last closing price of $238.43.
Analyst Price Targets (9 )
Broker Rating
ResMed currently has an average brokerage recommendation (ABR) of 2.23 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 2.17 a month ago based on 12 recommendations.
Of the 13 recommendations deriving the current ABR, six are Strong Buy, representing 46.15% of all recommendations. A month ago, Strong Buy represented 41.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 5 | 5 | 6 |
Buy | 0 | 0 | 0 | 1 | 2 |
Hold | 6 | 6 | 7 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 0 | 0 | 0 |
ABR | 2.23 | 2.23 | 2.17 | 2.08 | 1.96 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/24/2024 | Robert W. Baird & Co. | David Rescott | Not Available | Strong Buy |
9/18/2024 | Not Identified | Not Identified | Hold | Strong Sell |
9/4/2024 | Needham & Company | Michael Matson | Moderate Buy | Hold |
8/5/2024 | UBS | Laura Sutcliffe | Hold | Hold |
8/2/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
8/2/2024 | KeyBanc Capital Markets | Brett Fishbin | Strong Buy | Strong Buy |
8/2/2024 | William Blair | Margaret Kaczor | Strong Buy | Strong Buy |
8/2/2024 | Not Identified | Not Identified | Hold | Hold |
6/25/2024 | Not Identified | Not Identified | Strong Buy | Hold |
6/24/2024 | Not Identified | Not Identified | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.23 |
ABR (Last week) | 2.23 |
# of Recs in ABR | 13 |
Average Target Price | $238.10 |
LT Growth Rate | 12.30% |
Industry | Medical - Products |
Industry Rank by ABR | 51 of 252 |
Current Quarter EPS Est: | 2.03 |
RMD FAQs
ResMed Inc. (RMD) currently has an average brokerage recommendation (ABR) of 2.23 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms.
The average price target for ResMed Inc. (RMD) is $238.10. The current on short-term price targets is based on 5 reports.
The forecasts for ResMed Inc. (RMD) range from a low of $180 to a high of $280. The average price target represents a increase of $1.76 from the last closing price of $233.98.
The current UPSIDE for ResMed Inc. (RMD) is 1.76%
Based on short-term price targets offered by nine analysts, the average price target for ResMed comes to $233.44. The forecasts range from a low of $180.00 to a high of $270.00. The average price target represents a decline of 2.09% from the last closing price of $238.43.